Raymond U Osarogiagbon1, Meredith A Ray2, Nicholas R Faris3, Matthew P Smeltzer4, Carrie Fehnel3, Cheryl Houston-Harris3, Raymond S Signore3, Laura M McHugh3, Paul Levy5, Lynn Wiggins6, Vishal Sachdev7, Edward T Robbins3. 1. Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee. Electronic address: rosarogi@bmhcc.org. 2. Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee. 3. Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee. 4. Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee. 5. North East Arkansas Baptist Memorial Hospital, Jonesboro, Arkansas. 6. St. Bernard's Regional Medical Center, Jonesboro, Arkansas. 7. North Mississippi Medical Center, Tupelo, Mississippi.
Abstract
BACKGROUND: The National Comprehensive Cancer Network (NCCN) surgical resection guidelines for non-small cell lung cancer recommend anatomic resection, negative margins, examination of hilar/intrapulmonary lymph nodes, and examination of three or more mediastinal nodal stations. We examined the survival impact of these criteria. METHODS: A population-based observational study was done using patient-level data from all curative-intent, non-small cell lung cancer resections from 2004 to 2013 at 11 institutions in four contiguous Dartmouth Hospital referral regions in three US states. We used an adjusted Cox proportional hazards model to assess the overall survival impact of attaining NCCN guidelines. RESULTS: Of 2,429 eligible resections, 91% were anatomic, 94% had negative margins, 51% sampled hilar nodes, and 26% examined three or more mediastinal nodal stations. Only 17% of resections met all four criteria; however, there was a significant increasing trend from 2% in 2004 to 39% in 2013 (p < 0.001). Compared with patients whose surgery missed one or more criteria, the hazard ratio for patients whose surgery met all four criteria was 0.71 (95% confidence interval: 0.59 to 0.86, p < 0.001). Margin status and the nodal staging criteria were most strongly linked with survival. CONCLUSIONS: Attainment of NCCN surgical quality guidelines was low, but improving, over the past decade in this cohort from a high lung cancer mortality region of the United States. The NCCN quality criteria, especially the nodal examination criteria, were strongly associated with survival. The quality of nodal examination should be a focus of quality improvement in non-small cell lung cancer care.
BACKGROUND: The National Comprehensive Cancer Network (NCCN) surgical resection guidelines for non-small cell lung cancer recommend anatomic resection, negative margins, examination of hilar/intrapulmonary lymph nodes, and examination of three or more mediastinal nodal stations. We examined the survival impact of these criteria. METHODS: A population-based observational study was done using patient-level data from all curative-intent, non-small cell lung cancer resections from 2004 to 2013 at 11 institutions in four contiguous Dartmouth Hospital referral regions in three US states. We used an adjusted Cox proportional hazards model to assess the overall survival impact of attaining NCCN guidelines. RESULTS: Of 2,429 eligible resections, 91% were anatomic, 94% had negative margins, 51% sampled hilar nodes, and 26% examined three or more mediastinal nodal stations. Only 17% of resections met all four criteria; however, there was a significant increasing trend from 2% in 2004 to 39% in 2013 (p < 0.001). Compared with patients whose surgery missed one or more criteria, the hazard ratio for patients whose surgery met all four criteria was 0.71 (95% confidence interval: 0.59 to 0.86, p < 0.001). Margin status and the nodal staging criteria were most strongly linked with survival. CONCLUSIONS: Attainment of NCCN surgical quality guidelines was low, but improving, over the past decade in this cohort from a high lung cancer mortality region of the United States. The NCCN quality criteria, especially the nodal examination criteria, were strongly associated with survival. The quality of nodal examination should be a focus of quality improvement in non-small cell lung cancer care.
Authors: John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Raymond U Osarogiagbon; Laura E Miller; Robert A Ramirez; Christopher G Wang; Thomas F O'Brien; Xinhua Yu; Alim Khandekar; Glenn P Schoettle; Samuel G Robbins; Edward T Robbins; Jeffrey B Gibson Journal: J Thorac Oncol Date: 2012-08 Impact factor: 15.609
Authors: Matthew J Schuchert; Brian L Pettiford; Samuel Keeley; Thomas A D'Amato; Arman Kilic; John Close; Arjun Pennathur; Ricardo Santos; Hiran C Fernando; James R Landreneau; James D Luketich; Rodney J Landreneau Journal: Ann Thorac Surg Date: 2007-09 Impact factor: 4.330
Authors: Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart Journal: Ann Thorac Surg Date: 2005-12 Impact factor: 4.330
Authors: Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam Journal: J Thorac Cardiovasc Surg Date: 2011-03 Impact factor: 5.209
Authors: Rajwanth R Veluswamy; Nicole Ezer; Grace Mhango; Emily Goodman; Marcelo Bonomi; Alfred I Neugut; Scott Swanson; Charles A Powell; Mary B Beasley; Juan P Wisnivesky Journal: J Clin Oncol Date: 2015-08-03 Impact factor: 44.544
Authors: Meredith A Ray; Nicholas R Faris; Matthew P Smeltzer; Carrie Fehnel; Cheryl Houston-Harris; Paul Levy; Lynn Wiggins; Vishal Sachdev; Todd Robbins; David Spencer; Raymond U Osarogiagbon Journal: Ann Thorac Surg Date: 2018-03-11 Impact factor: 4.330
Authors: Matthew P Smeltzer; Nicholas R Faris; Meredith A Ray; Carrie Fehnel; Cheryl Houston-Harris; Philip Ojeabulu; Olawale Akinbobola; Yu-Sheng Lee; Meghan Meadows; R Samuel Signore; Lynn Wiggins; David Talton; Edmond Owen; Lawrence E Deese; Richard Eubanks; Bradley A Wolf; Paul Levy; E Todd Robbins; Raymond U Osarogiagbon Journal: Ann Thorac Surg Date: 2018-12-27 Impact factor: 4.330
Authors: Meredith A Ray; Carrie Fehnel; Olawale Akinbobola; Nicholas R Faris; Meghan Taylor; Alicia Pacheco; Matthew P Smeltzer; Raymond U Osarogiagbon Journal: J Thorac Oncol Date: 2021-02-12 Impact factor: 15.609
Authors: José Ramón Jarabo Sarceda; Sergio Bolufer Nadal; Roberto Mongil Poce; Pedro López de Castro; Ramón Moreno Balsalobre; Juan Carlos Peñalver Cuesta; Raul Embún Flor; Joaquín Pac Ferrer; Francisco Javier Algar Algar; Antonio Pablo Gámez García; Marcelo F Jiménez; Jesús Gabriel Sales-Badía; Eva Pereira; Bartomeu Massuti; Mariano Provencio; Florentino Hernando Trancho Journal: Transl Lung Cancer Res Date: 2021-04
Authors: Mitchell S von Itzstein; Rong Lu; Kemp H Kernstine; Ethan A Halm; Shidan Wang; Yang Xie; David E Gerber Journal: Cancer Med Date: 2020-04-21 Impact factor: 4.452
Authors: Fortuné M K Elekonawo; Jan Marie de Gooyer; Desirée L Bos; David M Goldenberg; Otto C Boerman; Lodewijk A A Brosens; Andreas J A Bremers; Johannes H W de Wilt; Mark Rijpkema Journal: Cancers (Basel) Date: 2020-04-17 Impact factor: 6.639
Authors: Matthew P Smeltzer; Yu-Sheng Lee; Nicholas R Faris M Div; Carrie Fehnel; Olawale Akinbobola; Meghan Meadows-Taylor; David Spencer; Elizabeth Sales; Sherry Okun; Christopher Giampapa; Amal Anga; Alicia Pacheco; Meredith A Ray; Raymond U Osarogiagbon Journal: J Thorac Oncol Date: 2021-07-16 Impact factor: 20.121
Authors: Ryan K Orosco; Viridiana J Tapia; Joseph A Califano; Bryan Clary; Ezra E W Cohen; Christopher Kane; Scott M Lippman; Karen Messer; Alfredo Molinolo; James D Murphy; John Pang; Assuntina Sacco; Kathryn R Tringale; Anne Wallace; Quyen T Nguyen Journal: Sci Rep Date: 2018-04-09 Impact factor: 4.379